Trial Profile
Efficacy of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in Type 2 diabetes patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Dec 2015 New trial record